Evidence map›Paper›PMID 35807549›Full record

ReviewMolecules (Basel, Switzerland)2022

Pharmacological Properties of 4', 5, 7-Trihydroxyflavone (Apigenin) and Its Impact on Cell Signaling Pathways.

Rameesha Abid, Shakira Ghazanfar, Arshad Farid, Samra Muhammad Sulaman, Maryam Idrees, Radwa Abdallnasser Amen, Muhammad Muzammal, Muhammad Khurram Shahzad, Mohamed Omar Mohamed, Alaa Ashraf Khaled and 4 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05788705 (Evaluation of the Efficacy of Natural JAK_ STAT Pathways Inhibitors in Treatment of Patients With Rheumatoid Arthritis as a Complementary Medicine), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05788705 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Evaluation of the Efficacy of Natural JAK_ STAT Pathways Inhibitors in Treatment of Patients With Rheumatoid Arthritis as a Complementary Medicine

TypeinterventionalSponsorAdel A.GomaaRan2023 to 2025Enrolled75ConditionsRheumatoid ArthritisArms"apigenin" and "glycyrrhizin", "glycyrrhizin" and "boswellic acid", "placebo"
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 4 countries.

Rameesha AbidDepartment of Biotechnology, University of Sialkot, Sialkot 51310, Pakistan.ORCID 0000-0002-0464-5477
Shakira GhazanfarNational Institute for Genomics and Advanced Biotechnology (NIGAB), National Agricultural Research Center, Islamabad 44100, Pakistan.ORCID 0000-0002-6277-5106
Arshad FaridGomal Center of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan 29050, Pakistan.ORCID 0000-0001-5147-5936
Samra Muhammad SulamanBiotechnology Department, University of Gujrat, Punjab 50700, Pakistan.
Maryam IdreesNational Institute for Genomics and Advanced Biotechnology (NIGAB), National Agricultural Research Center, Islamabad 44100, Pakistan.ORCID 0000-0001-6948-841X
Radwa Abdallnasser AmenBiotechnology Department, Faculty of Science, Cairo University, Cairo 424010, Egypt.
Muhammad MuzammalGomal Center of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan 29050, Pakistan.
Muhammad Khurram ShahzadBiotechnology and Bioinformatics Department, International Islamic University, Islamabad 44100, Pakistan.
Mohamed Omar MohamedFaculty of Agriculture, Ain Shams University, Cairo 424010, Egypt.
Alaa Ashraf KhaledFaculty of Agriculture, Benha University, Benha 13511, Egypt.
Waqas SafirCollege of Life Science and Technology, Xinjiang University, Urumqi 830046, China.ORCID 0000-0003-2887-9224
Ifra GhoriDepartment of Biotechnology, Fatima Jinnah Women University, Rawalpindi 46000, Pakistan.
Abdelbaset Mohamed ElasbaliDepartment of Clinical Laboratory Science, College of Applied Sciences-Qurayyat, Jouf University, Sakaka 72388, Saudi Arabia.ORCID 0000-0002-7003-9846
Bandar AlharbiDepartment of Medical Laboratory, College of Applied Medical Science, University of Hail, Hail 81481, Saudi Arabia.
Gomal University · PKAin Shams University · EGBenha University · EGCairo University · EGFatima Jinnah Women University · PKInternational Islamic University, Islamabad · PKJouf University · SAQuaid-i-Azam University · PKUniversity of Gujrat · PKUniversity of Ha'il · SAUniversity of SialkotXinjiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant bioactive compounds, particularly apigenin, have therapeutic potential and functional activities that aid in the prevention of infectious diseases in many mammalian bodies and promote tumor growth inhibition. Apigenin is a flavonoid with low toxicities and numerous bioactive properties due to which it has been considered as a traditional medicine for decades. Apigenin shows synergistic effects in combined treatment with sorafenib in the HepG2 human cell line (HCC) in less time and statistically reduces the viability of tumor cells, migration, gene expression and apoptosis. The combination of anti-cancerous drugs with apigenin has shown health promoting potential against various cancers. It can prevent cell mobility, maintain the cell cycle and stimulate the immune system. Apigenin also suppresses mTOR activity and raises the UVB-induced phagocytosis and reduces the cancerous cell proliferation and growth. It also has a high safety threshold, and active (anti-cancer) doses can be gained by consuming a vegetable and apigenin rich diet. Apigenin also boosted autophagosome formation, decreased cell proliferation and activated autophagy by preventing the activity of the PI3K pathway, specifically in HepG2 cells. This paper provides an updated overview of apigenin's beneficial anti-inflammatory, antibacterial, antiviral, and anticancer effects, making it a step in the right direction for therapeutics. This study also critically analyzed the effect of apigenin on cancer cell signaling pathways including the PI3K/AKT/MTOR, JAK/STAT, NF-κB and ERK/MAPK pathways.

Indexed as

ApigeninPhosphatidylinositol 3-KinasesAnimalsApoptosisCell Line, TumorCell ProliferationHumansMammalsProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine KinasesApigeninPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesapigeninapoptosisflavonoidROSsignaling cascades

Identifiers

PMID35807549
PMCPMC9267958
OpenAlexW4283820628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.